The GLP-1RA drugs semaglutide and liraglutide, due to their longer half-lives, may have more prolonged effects in the CNS and regulate appetite metabolic processes (30)
Ozempic is approved by the Food and Drug Administration (FDA) for the following uses: to improve blood sugar management in adults who have type 2 diabetes, when used along with diet and exercise to reduce the risk of major cardiovascular events (those related to the heart and blood vessels, such as heart attack, stroke, and death) in adults who have type 2 diabetes and cardiovascular disease to reduce the risk of complications from chronic kidney disease in adults with type 2 diabetes The FDA has not approved Ozempic for weight loss or long-term weight management
GLP-1 medications are not a quick fix or a one-size-fits-all solution
At Majestic Aesthetics, our Semaglutide Weight Loss Program Lake Worth is designed to help patients lose weight safely and effectively with FDA-approved injections
Find more information Speak to a medical representative If you are a healthcare provider from the United States, click below to request information directly from the Novo Nordisk Medical Information department